2009 - Fellow of the American Association for the Advancement of Science (AAAS)
2005 - Oswald Avery Award, Infectious Diseases Society of America
James E. Crowe focuses on Virology, Virus, Antibody, Monoclonal antibody and Epitope. His biological study spans a wide range of topics, including Molecular biology, Mutant and Antigen. His Virus study combines topics in areas such as Mutagenesis and Immunogenicity.
His Antibody research is included under the broader classification of Immunology. James E. Crowe has researched Monoclonal antibody in several fields, including Alphavirus, Humoral immunity, Plasma protein binding and Glycoprotein. His work in the fields of Epitope mapping overlaps with other areas such as Immunoglobulin Fab Fragments.
His primary scientific interests are in Virology, Antibody, Virus, Monoclonal antibody and Epitope. His research in Virology intersects with topics in Glycoprotein and Immunology, Immune system, Antigen. His Antibody study deals with Dengue virus intersecting with Serotype.
His Virus study integrates concerns from other disciplines, such as Respiratory system and Microbiology. His studies in Monoclonal antibody integrate themes in fields like Humoral immunity and Zika virus. His work carried out in the field of Epitope brings together such families of science as Flavivirus, Neutralizing antibody, Fusion protein and Dengue fever.
James E. Crowe mostly deals with Antibody, Virology, Monoclonal antibody, Epitope and Antigen. His work deals with themes such as Dengue virus, Computational biology, Glycoprotein and Severe acute respiratory syndrome coronavirus 2, which intersect with Antibody. Many of his studies on Virology involve topics that are commonly interrelated, such as Immune system.
His Monoclonal antibody study incorporates themes from Vero cell, Humoral immunity, In vivo and Coronavirus. The concepts of his Epitope study are interwoven with issues in Alphavirus, Ross River virus, Ebola virus and Fusion protein. His Virus research incorporates themes from Plasma protein binding and Antibody Repertoire.
His primary areas of study are Antibody, Virology, Monoclonal antibody, Epitope and Virus. Antibody is a subfield of Immunology that James E. Crowe studies. His study in Virology is interdisciplinary in nature, drawing from both Vector and Immunity.
James E. Crowe has included themes like Vero cell, Neutralizing antibody, Inflammation, Neutralization and Glycoprotein in his Monoclonal antibody study. The various areas that he examines in his Epitope study include Humoral immunity and Ebola virus. His study on Virus also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.
John V. Williams;Paul A. Harris;Sharon J. Tollefson;Lisa L. Halburnt-Rush.
The New England Journal of Medicine (2004)
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein.
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.
Allison J. Greaney;Allison J. Greaney;Tyler N. Starr;Pavlo Gilchuk;Seth J. Zost.
Cell Host & Microbe (2021)
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus
Rui Xu;Damian C. Ekiert;Jens C. Krause;Rong Hai.
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
Rita E. Chen;Xianwen Zhang;James Brett Case;Emma S. Winkler.
Nature Medicine (2021)
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Xiaocong Yu;Tshidi Tsibane;Patricia A. McGraw;Frances S. House.
Proof of principle for epitope-focused vaccine design
Bruno Emanuel F. Sousa Correia;John T. Bates;Rebecca J. Loomis;Gretchen Baneyx.
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.
Seth J. Zost;Pavlo Gilchuk;Rita E. Chen;James Brett Case.
Nature Medicine (2020)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
Ruklanthi De Alwis;Scott A. Smith;Nicholas P. Olivarez;William B. Messer.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson.
The Journal of Infectious Diseases (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: